Assessing the removal of pharmaceuticals and personal care products in a full-scale activated sludge plant

PurposeThis study aimed to investigate the removal mechanisms of pharmaceutical active compounds (PhACs) and musks in a wastewater treatment plant (WWTP). Biological removal and adsorption in the activated sludge tank as well as the effect of UV radiation used for disinfection purposes were considered when performing a mass balance on the WWTP throughout a 2-week sampling campaign.MethodsSolid-phase extraction (SPE) was carried out to analyse the PhACs in the influent and effluent samples. Ultrasonic solvent extraction was used before SPE for PhACs analysis in sludge samples. PhAC extracts were analysed by LC-MS. Solid-phase microextraction of liquid and sludge samples was used for the analysis of musks, which were detected by GC-MS. The fluxes of the most abundant compounds (13 PhACs and 5 musks) out of 79 compounds studied were used to perform the mass balance on the WWTP.ResultsResults show that incomplete removal of diclofenac, the compound that was found in the highest abundance, was observed via biodegradation and adsorption, and that UV photolysis was the main removal mechanism for this compound. The effect of adsorption to the secondary sludge was often negligible for the PhACs, with the exceptions of diclofenac, etofenamate, hydroxyzine and indapamide. However, the musks showed a high level of adsorption to the sludge. UV radiation had an important role in reducing the concentration of some of the target compounds (e.g. diclofenac, ibuprofen, clorazepate, indapamide, enalapril and atenolol) not removed in the activated sludge tank.ConclusionsThe main removal mechanism of PhACs and musks studied in the WWTP was most often biological (45%), followed by adsorption (33%) and by UV radiation (22%). In the majority of the cases, the WWTP achieved >75% removal of the most detected PhACs and musks, with the exception of diclofenac.

[1]  M. Reis,et al.  Analysis of 65 pharmaceuticals and personal care products in 5 wastewater treatment plants in Portugal using a simplified analytical methodology. , 2010, Water Science and Technology.

[2]  David M. Cwiertny,et al.  Pharmaceuticals and personal care products in effluent matrices: A survey of transformation and removal during wastewater treatment and implications for wastewater management. , 2010, Journal of environmental monitoring : JEM.

[3]  A. Mittal,et al.  Batch and bulk removal of a triarylmethane dye, Fast Green FCF, from wastewater by adsorption over waste materials. , 2009, Journal of hazardous materials.

[4]  M. Clara,et al.  Occurrence of polycyclic musks in wastewater and receiving water bodies and fate during wastewater treatment. , 2011, Chemosphere.

[5]  E. Arnold,et al.  Standard methods for the examination of water and wastewater. 16th ed. , 1985 .

[6]  A. Mittal,et al.  Adsorption of Safranin-T from wastewater using waste materials- activated carbon and activated rice husks. , 2006, Journal of colloid and interface science.

[7]  D. Barceló,et al.  Occurrence, partition and removal of pharmaceuticals in sewage water and sludge during wastewater treatment. , 2011, Water research.

[8]  H. Takada,et al.  Pharmaceutical chemicals and endocrine disrupters in municipal wastewater in Tokyo and their removal during activated sludge treatment. , 2006, Water research.

[9]  V. Belgiorno,et al.  Degradation of diclofenac during sonolysis, ozonation and their simultaneous application. , 2009, Ultrasonics sonochemistry.

[10]  V. Sharma.  Oxidative transformations of environmental pharmaceuticals by Cl₂, ClO₂, O₃, and Fe(VI): kinetics assessment. , 2008, Chemosphere.

[11]  Damià Barceló,et al.  Fate and distribution of pharmaceuticals in wastewater and sewage sludge of the conventional activated sludge (CAS) and advanced membrane bioreactor (MBR) treatment. , 2009, Water research.

[12]  S. Esplugas,et al.  Mineralization enhancement of a recalcitrant pharmaceutical pollutant in water by advanced oxidation hybrid processes. , 2009, Water research.

[13]  Adriano Joss,et al.  Occurrence and sorption behavior of sulfonamides, macrolides, and trimethoprim in activated sludge treatment. , 2005, Environmental science & technology.

[14]  N. Nakada,et al.  Occurrence and fate of anti-inflammatory drugs in wastewater treatment plants in Japan. , 2005, Environmental sciences : an international journal of environmental physiology and toxicology.

[15]  D. Calamari,et al.  Pharmaceuticals in the Environment in Italy: Causes, Occurrence, Effects and Control , 2006, Environmental science and pollution research international.

[16]  D. Blowes,et al.  Fate of pharmaceutical and trace organic compounds in three septic system plumes, Ontario, Canada. , 2008, Environmental science & technology.

[17]  A Oehmen,et al.  Assessing the diurnal variability of pharmaceutical and personal care products in a full-scale activated sludge plant. , 2011, Environmental pollution.

[18]  Adriano Joss,et al.  Removal of pharmaceuticals and fragrances in biological wastewater treatment. , 2005, Water research.

[19]  T. Ternes,et al.  Assessment of the importance of sorption for steroid estrogens removal during activated sludge treatment. , 2005, Chemosphere.

[20]  M. Clara,et al.  Investigation on the behaviour of selected pharmaceuticals in the groundwater after infiltration of treated wastewater. , 2004, Water science and technology : a journal of the International Association on Water Pollution Research.

[21]  Christoph Ort,et al.  Sampling for pharmaceuticals and personal care products (PPCPs) and illicit drugs in wastewater systems: are your conclusions valid? A critical review. , 2010, Environmental science & technology.

[22]  A. Nayak,et al.  Adsorption studies on the removal of hexavalent chromium from aqueous solution using a low cost fertilizer industry waste material. , 2010, Journal of colloid and interface science.

[23]  Marta Carballa,et al.  Calculation methods to perform mass balances of micropollutants in sewage treatment plants. application to pharmaceutical and personal care products (PPCPs). , 2007, Environmental science & technology.

[24]  J. Hartmann,et al.  Degradation of the drug diclofenac in water by sonolysis in presence of catalysts. , 2008, Chemosphere.

[25]  Kevin V Thomas,et al.  Impacts of competitive inhibition, parent compound formation and partitioning behavior on the removal of antibiotics in municipal wastewater treatment. , 2010, Environmental science & technology.

[26]  H. Kroiss,et al.  The solids retention time-a suitable design parameter to evaluate the capacity of wastewater treatment plants to remove micropollutants. , 2005, Water research.

[27]  Marta Carballa,et al.  Behavior of pharmaceuticals, cosmetics and hormones in a sewage treatment plant. , 2004, Water research.

[28]  J. Dewulf,et al.  Ozonation and advanced oxidation by the peroxone process of ciprofloxacin in water. , 2009, Journal of hazardous materials.

[29]  A. E. Greenberg,et al.  Standard Methods for the Examination of Water and Wastewater seventh edition , 2013 .

[30]  W. Püttmann,et al.  Occurrence and removal of lidocaine, tramadol, venlafaxine, and their metabolites in German wastewater treatment plants , 2012, Environmental Science and Pollution Research.

[31]  A. Mittal,et al.  Adsorption of hazardous dye crystal violet from wastewater by waste materials. , 2010, Journal of colloid and interface science.

[32]  K. Xiao,et al.  Elimination and fate of selected micro-organic pollutants in a full-scale anaerobic/anoxic/aerobic process combined with membrane bioreactor for municipal wastewater reclamation. , 2010, Water research.

[33]  M. Guida,et al.  Fate of pharmaceuticals in contaminated urban wastewater effluent under ultrasonic irradiation. , 2009, Water research.

[34]  Bent Halling-Sørensen,et al.  Fate of estrogens in a municipal sewage treatment plant. , 2003, Environmental science & technology.

[35]  T. Ternes,et al.  Ecotoxicologial evaluation of wastewater ozonation based on detritus-detritivore interactions. , 2011, Chemosphere.

[36]  Adriano Joss,et al.  Biological degradation of pharmaceuticals in municipal wastewater treatment: proposing a classification scheme. , 2006, Water research.

[37]  Sun-Kyoung Shin,et al.  Occurrence and distribution of pharmaceuticals in wastewater from households, livestock farms, hospitals and pharmaceutical manufactures. , 2011, Chemosphere.

[38]  Adriano Joss,et al.  A rapid method to measure the solid-water distribution coefficient (Kd) for pharmaceuticals and musk fragrances in sewage sludge. , 2004, Water research.

[39]  H Kroiss,et al.  Removal of selected pharmaceuticals, fragrances and endocrine disrupting compounds in a membrane bioreactor and conventional wastewater treatment plants. , 2005, Water research.

[40]  Joop L M Hermens,et al.  Removal of two polycyclic musks in sewage treatment plants: freely dissolved and total concentrations. , 2003, Environmental science & technology.

[41]  F. Gagné,et al.  Occurrence of pharmaceutical products in a municipal effluent and toxicity to rainbow trout (Oncorhynchus mykiss) hepatocytes. , 2006, Ecotoxicology and environmental safety.